Skip to main content

LivaNova PLC

corporate_fare Company Profile

LivaNova PLC

LIVN·NASDAQ·Industrial Applications And Services·CIK 0001639691

LivaNova PLC is a global medical technology company that designs, develops, manufactures, markets, and sells medical products, therapies, and services. The company is organized under the laws of England and Wales, headquartered in London, England, and its ordinary shares trade on Nasdaq under the symbol "LIVN." LivaNova operates through two reportable segments: Cardiopulmonary and Neuromodulation. The "Other" category includes non-allocated corporate expenses and non-cannula results from the former ACS segment, which was wound down during 2024. The Cardiopulmonary segment focuses on the design, development, manufacture, marketing, and sale of cardiopulmonary products and related services. Key products include heart-lung machines (HLMs), oxygenators, autotransfusion systems, perfusion tubing systems, and cannulae. This segment features the Essenz Perfusion System, an HLM with an embedded patient monitor and sensing technology for data-driven decisions during cardiopulmonary bypass (CPB) procedures. CPB is used in heart-related medical procedures, such as coronary artery bypass grafting and valve surgeries, to oxygenate and circulate a patient's blood. LivaNova's products support CPB for neonatal, pediatric, and adult patients. The HLM product group specifically includes HLMs, heater-coolers, related cardiac surgery equipment, and maintenance and technical services. HLMs temporarily take over heart and/or lung functions, circulating blood and oxygen to the body while the heart is stopped during cardiac surgery.

LivaNova PLC (NASDAQ:LIVN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for LIVN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for LIVN spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • LivaNova Q3: Revenue Up 9.9% but $34M Heater-Cooler Charge Cuts Operating Income to $28.4M
  • LivaNova Posts $393.1M in Third-Quarter Revenue
  • LivaNova Tops Q3 Revenue Estimates and Lifts Full-Year 2026 Guidance
  • LivaNova Launches Epilepsy App, Scores €82M Tax Win, Needham Lifts PT to $93
  • LivaNova Beats Q2 Estimates, Raises Full-Year Guidance on Strong Cardiopulmonary and Neuromodulation Growth

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.39B
Net Income
-$242.47M
Diluted EPS
-$4.45
Op. Cash Flow
$254.34M
Free Cash Flow
$173.29M
Gross Profit
$939.87M
Operating Income
$199.39M
Cash & Equivalents
$635.55M
Total Debt
$376.06M
Debt / Equity
0.31×
Net Margin
-17.5%
Shares Outstanding
54.65M sh
Source: 10-K · filed 2026-02-25 · accession 0001639691-26-000010

Short Interest & Short Volume

12.42 days to cover

FINRA reported short interest of 6,362,366 shares in LIVN as of the October 30, 2026 settlement, a 2.6% increase from the prior period — about 12.4 days to cover at its recent average daily volume. On November 20, 2026, 66.4% of LIVN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)6,362,366 shares as of October 30, 2026
Change vs prior period▲ 2.6%
Days to cover12.42 at avg daily volume of 512,265
Daily short volume (FINRA facilities)66.4% of 150,729 shares on November 20, 2026
5-day average short volume72.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with L →
$90.73
52-week range · as of 2026-11-04 $48.82 – $99.38
Market cap
$5B
Volume
536.7K (0.7× avg)
3-mo avg 754K
Live data · 2026-11-22 06:08 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LIVN - Latest Insights

LIVN
Nov 04, 2026, 3:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $96.42
Real-time Price: $90.73 info
Change: -$5.69 (-6%) info
Market Cap: $4.998B info
LIVN
Nov 04, 2026, 6:02 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $79.90
Real-time Price: $90.73 info
Change: +$10.83 (+14%) info
Market Cap: $4.998B info
LIVN
Nov 04, 2026, 6:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.90
Real-time Price: $90.73 info
Change: +$10.83 (+14%) info
Market Cap: $4.998B info
LIVN
Aug 06, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $78.15
Real-time Price: $90.73 info
Change: +$12.59 (+16%) info
Market Cap: $4.998B info
LIVN
Aug 05, 2026, 2:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $76.37
Real-time Price: $90.73 info
Change: +$14.36 (+19%) info
Market Cap: $4.998B info
LIVN
Aug 05, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $87.49
Real-time Price: $90.73 info
Change: +$3.24 (+4%) info
Market Cap: $4.998B info
LIVN
Aug 05, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $87.49
Real-time Price: $90.73 info
Change: +$3.24 (+4%) info
Market Cap: $4.998B info
LIVN
Jun 16, 2026, 12:58 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $80.64
Real-time Price: $90.73 info
Change: +$10.09 (+13%) info
Market Cap: $4.998B info
LIVN
Jun 11, 2026, 9:07 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $79.01
Real-time Price: $90.73 info
Change: +$11.72 (+15%) info
Market Cap: $4.998B info
LIVN
May 06, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $57.70
Real-time Price: $90.73 info
Change: +$33.03 (+57%) info
Market Cap: $4.998B info
LIVN
May 06, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $57.70
Real-time Price: $90.73 info
Change: +$33.03 (+57%) info
Market Cap: $4.998B info
LIVN
Apr 29, 2026, 8:30 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $61.41
Real-time Price: $90.73 info
Change: +$29.32 (+48%) info
Market Cap: $4.998B info
LIVN
Feb 25, 2026, 3:26 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $70.36
Real-time Price: $90.73 info
Change: +$20.37 (+29%) info
Market Cap: $4.998B info
LIVN
Feb 25, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $69.05
Real-time Price: $90.73 info
Change: +$21.68 (+31%) info
Market Cap: $4.998B info
LIVN
Jan 14, 2026, 8:32 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $61.35
Real-time Price: $90.73 info
Change: +$29.38 (+48%) info
Market Cap: $4.998B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets